Skip to main content

Advertisement

SpringerLink
Log in

Sulfonamide Drug Allergy

  • Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

We sought to review past and current literature on sulfonamide drug allergy and distill it in a practical manner to assist the clinician, specifically focusing on cross-reactivity and desensitization.

Recent Findings

There do not appear to be consistent genetic markers to reliably predict features of or the presence hypersensitivity reactions. Recent evidence continues to alleviate early concerns cross-reactivity between sulfonamide antibiotics and non-antibiotics.

Summary

Sulfonamide drug allergy is frequently encountered by the practicing clinician. For sulfonamide antibiotics, delayed rash is the most common clinical manifestation. There is no current evidence to support avoidance of all non-antibiotic sulfonamides in those with a reported allergy to sulfonamide antibiotics, although certain scenarios require caution. Available evidence supports the cautious reintroduction of sulfonamide antibiotics via desensitization, which is usually well tolerated and should be considered in those with strong indications for trimethoprim-sulfamethoxazole and a reported sulfonamide allergy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as:• Of importance •• Of major importance

  1. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions: a report from the Boston collaborative drug surveillance program on 15 438 consecutive inpatients, 1975 to 1982.

  2. Macy E, Poon K-YT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med. 2009;

  3. McConeghy KW, Caffrey AR, Morrill HJ, Trivedi AN, LaPlante KL. Are non-allergic drug reactions commonly documented as medication “allergies”? A national cohort of veterans’ admissions from 2000 to 2014. Pharmacoepidemiol Drug Saf. 2017;26:472–6.

    Article  PubMed  CAS  Google Scholar 

  4. Anon. Co-trimoxazole and blood. Lancet. Lancet 1973;2:950.

  5. Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients (review). Cochrane Database Syst Rev. 2014:1–67.

  6. Brackett CC, Harleen S, Likelihood BJ. Mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group. Pharmacotherapy. 2004;24:856–70.

    Article  PubMed  CAS  Google Scholar 

  7. Wulf NR, Matuszewski KA. Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? Am J Heal Pharm. 2013;70:1483–94.

    Article  CAS  Google Scholar 

  8. Lehmann FD. The metabolic rationale for a lack of cross-reactivity between sulfonamide antimicrobials and other sulfonamide-containing drugs. Drug Metab Lett [Internet]. 2012;6:129–33. Available from: http://openurl.ingenta.com/content/xref?genre=article&issn=1872-3128&volume=6&issue=2&spage=129

    Article  CAS  Google Scholar 

  9. Ghimire S, Kyung E, Lee JH, Kim JW, Kang W, Kim E. An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications. J Clin Pharm Ther. 2013;38:196–202.

    Article  PubMed  CAS  Google Scholar 

  10. Johnson KK, Green DL, Rife JP, Limon L. Sulfonamide cross-reactivity: fact or fiction? Ann Pharmacother. 2005;39:290–301.

    Article  PubMed  CAS  Google Scholar 

  11. Verdel BM, Souverain PC, Egberts ACG, Leufkens HGM. Difference in risks of allergic reactions to sulfonamide drugs based on chemical structure. Ann Pharmacother. 2006;40:1040–6.

    Article  PubMed  CAS  Google Scholar 

  12. Cribb AE, Lee BL, Trepanier LA, Spielberg SP. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Advers drug react. Toxicol Rev. 1996;15:9–50.

    CAS  Google Scholar 

  13. Harle DG, Baldo BA, Wells JV. Drugs as allergens: detection and combining site specificities of IgE. Mol Immunol. 1988;25:1347–54.

    Article  PubMed  CAS  Google Scholar 

  14. Pichler WJ, Adam J, Watkins S, Wuillemin N, Yun J, Drug Hypersensitivity YD. How drugs stimulate T cells via pharmacological interaction with immune receptors. Int Arch Allergy Immunol. 2015;168:13–24.

    Article  PubMed  CAS  Google Scholar 

  15. Reilly TP, Mechanistic JC. Perspectives on sulfonamide-induced cutaneous drug reactions. Curr Opin Allergy Clin Immunol. 2002;2:307–15.

    Article  PubMed  Google Scholar 

  16. Wang D, Curtis A, Papp AC, Koletar SL, Para MF. Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients. Biomed Cent Med. Genomics. 2012;5:1–9.

    Article  CAS  Google Scholar 

  17. • Reinhart JM, Motsinger-Reif A, Dickey A, Yale S, Trepanier LA. Genome-wide association study in immunocompetent patients with delayed hypersensitivity to sulfonamide antimicrobials. PLoS One. 2016;11:1–15. No convincing genetic risk factors found in this population with sulfonamide hypersensitivity.

    Google Scholar 

  18. Sacco J, Abouraya M, Motsinger-Reif A, Yale S, McCarty C, Trepanier L. Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity. Pharmacogenet Genomics. 2012;22:733–40.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Kongpan T, Mahasirimongkol S, Konyoung P, Kanjanawart S, Chumworathayi P, Wichukchinda N, et al. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. Pharmacogenet Genomics. 2015;25:402–11.

    Article  PubMed  CAS  Google Scholar 

  20. Zalewska-Janowska A, Spiewak R, Kowalski ML. Cutaneous manifestation of drug allergy and hypersensitivity. Immunol Allergy Clin N Am. 2017;37:165–81.

    Article  Google Scholar 

  21. Bӧhm R, Cascorbi I. Pharmacogenetics and predictive testing of drug hypersensitivity reactions. Front Pharmacol. 2016;7:1–11.

    Article  Google Scholar 

  22. Muraro A, Lemanske RF, Castells M, Torres MJ, Khan D, Simon HU, et al. Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European academy of allergy and clinical immunology and the American Academy of Allergy, Asthma and Immunology. Allergy Eur. J Allergy Clin Immunol. 2017;72:1006–21.

    Article  CAS  Google Scholar 

  23. Weiss ME, Bernstein DI, Blessing-moore J, Cox L, Lang DM, Nicklas RA, et al. Drug allergy: an updated practice parameter. Ann allergy, asthma Immunol. Ann. Allergy Asthma Immunol; 2010;105. 259–273:e78.

  24. Kuyucu S, Mori F, Atanaskovic-Markovic M, Caubet JC, Terreehorst I, Gomes E, et al. Hypersensitivity reactions to non-betalactam antibiotics in children: an extensive review. Pediatr Allergy Immunol. 2014;25:534–43.

    PubMed  Google Scholar 

  25. Sharma V, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents—a 6 year series from Chandigarh. India J Postgr Med. 2001;47:95–9.

    CAS  Google Scholar 

  26. Hansbrough JR, Wedner J, Chaplin DD. Anaphylaxis to intravenous furosemide. J Allergy Clin Immunol. 1987;80:538–41.

    Article  PubMed  CAS  Google Scholar 

  27. Slatore CG, Tilles SA. Sulfonamide Hypersensitivity. Immunol Allergy Clin N Am. 2004;24:477–90.

    Article  Google Scholar 

  28. Author S, Platt R, Dreis MW, Kennedy DL, Kuritsky JN. Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim. Source J Infect Dis [Internet]. 1988;158:474–7.

    Article  Google Scholar 

  29. Moreno Escobosa M, Granados SC, Quesada MM, Lopez JA. Enanthema and Fixed drug eruption caused by trimethoprim. J Investig Allergol Clin Immunol. 2009;19:237–52.

    Google Scholar 

  30. Bonfanti P, Pusterla L, Parazzini F, Libanore M, Cagni AE, Franzetti M, et al. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. Biomed Pharmacother. 2000;54:45–9.

    Article  PubMed  CAS  Google Scholar 

  31. Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH. Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood. 1994;84:176–83.

    PubMed  CAS  Google Scholar 

  32. George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematol Am Soc Hematol Educ Progr. 2009:153–8.

  33. Sanofi-Aventis. LASIX (furosemide). sanofi-aventis,US LLC. 2011;1–11.

  34. Dibbern DA, Montanaro A. Allergies to sulfonamide antibiotics, Allergy s-c d A. Asthma Immunol. American College of Allergy. Asthma & Immunology. 2008;100:91–101.

    Article  CAS  Google Scholar 

  35. Lin D, Tucker MJ, Rieder MJ. Increased adverse drug reactions to antimicrobials and anticonvulsants in patients with HIV infection. Ann Pharmacother. 2006;

  36. Hoetzenecker W, Nägeli M, Mehra ET, Jensen AN, Saulite I, Schmid-Grendelmeier P, et al. Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol. 2016;

  37. Roujeau J-C, Kelly J, Luigi N, Berthold R, Stern R. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600–7.

    Article  PubMed  CAS  Google Scholar 

  38. Wright AA, Vesta KS, Stark JE, Smith WJ. Stevens-Johnson syndrome associated with furosemide: a case report. J Pharm Pract. 2010;23:367–70.

    Article  PubMed  Google Scholar 

  39. Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071–80.

    Article  PubMed  CAS  Google Scholar 

  40. Feldmeyer L, Heidemeyer K, Yawalkar N. Acute generalized exanthematous pustulosis: pathogenesis, genetic background, clinical variants and therapy. Int J Mol Sci. 2016;17

  41. Anliker MD, Wüthrich B. Acute generalized exanthematous pustulosis due to sulfamethoxazol with positive lymphocyte transformation test (LTT). J Investig Allergol Clin Immunol. 2003;13:66–8.

    PubMed  Google Scholar 

  42. Lloyd-Lavery A, Chi C-C, Wojnarowska F, Taghipour K. The associations between bullous pemphigoid and drug use. JAMA Dermatology. 2013;149:58.

    Article  PubMed  Google Scholar 

  43. Kidon MI, See Y, Kidon MI. Adverse drug reactions in Singaporean children. Singap Med J. 2004;45

  44. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions: a report from the Boston collaborative drug surveillance program on 15 438 consecutive inpatients, 1975 to 1982. JAMA J Am Med Assoc. 1986;256:3358–63.

    Article  CAS  Google Scholar 

  45. Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol. 2015;

  46. Gruchalla RS. Diagnosis of allergic reactions to sulfonamides. Allergy. 1999;54:28–32.

    Article  PubMed  Google Scholar 

  47. Gompels MM, Simpson N, Snow M, Spickett G, Ong E. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction? J Inf Secur. 1999;38:111–5.

    CAS  Google Scholar 

  48. Doña I, Torres MJ, Montañez MI, Fernández TD. In vitro diagnostic testing for antibiotic allergy. Allergy Asthma Immunol Res. 2017;9:288.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Kalish RS, LaPorte A, Wood JAJK. Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. J Allergy Clin Immunol. 1994;Sep:465–72.

    Article  Google Scholar 

  50. Neuman MG, Malkiewicz IM, Phillips EJ, Rachlis AR, Ong D, Yeung E, et al. Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals. Ther Drug Monit. 2002;24:728–36.

    Article  PubMed  CAS  Google Scholar 

  51. Leoung GS, Stanford JF, Giordano MF, Stein A, Torres RA, Giffen CA, et al. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for pneumocystis carinii prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. J Infect Dis. 2001;184:992–7.

    Article  PubMed  CAS  Google Scholar 

  52. Shakoor MT, Ayub S, Ayub Z. Sulfa allergy: cross-reactivity versus multiple concurrent allergies. Am J Infect Dis. 2013;9:148–54.

    Article  CAS  Google Scholar 

  53. Castrejon JL, Berry N, El-Ghaiesh S, Gerber B, Pichler WJ, Park BK, et al. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. J Allergy Clin Immunol. 2010;125:411–8.

    Article  PubMed  CAS  Google Scholar 

  54. Tornero P, De Barrio M, Baeza ML, Herrero T. Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing. Contact Dermatitis. 2004;51:57–62.

    Article  PubMed  CAS  Google Scholar 

  55. Wenyang Fu L, Vender RB. Sulfa or sulfur? Clearing things up. J of cutaneous medicine and. Surgery. 2013;17:79–81.

    Google Scholar 

  56. Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol [Internet]. 2003;4:473–92. Available from: http://link.springer.com/article/10.2165/00128071-200304070-00004

    Article  Google Scholar 

  57. Dibbern DA, Montanaro A. Allergies to sulfonamide antibiotics and sulfur-containing drugs. Ann Allergy Asthma Immunol. 2008;100:91–101.

    Article  PubMed  CAS  Google Scholar 

  58. Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy SCE, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med. 2003;349:1628–35.

    Article  PubMed  CAS  Google Scholar 

  59. Hemstreet BA, Sulfonamide Allergies PRL. Outcomes related to use of potentially cross-reactive drugs in hospitalized patients. Pharmacotherapy. 2006;26:551–7.

    Article  PubMed  CAS  Google Scholar 

  60. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenic in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507–16.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  61. Marras TK, Sanders K, Lipton JH, Messner HA, Conly J, Chan CK. Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation. Transpl Infect Dis. 2002;Jun:66–74.

    Article  Google Scholar 

  62. Hughes WT. Use of dapsone in the prevention and treatment of pneumocystis carinii pneumonia: a review. Clin Infect Dis. 1998;27:191–204.

    Article  PubMed  CAS  Google Scholar 

  63. Stern A, Green H, Paul M, Vidal L, Leibovici L, Stern A, et al. Prophylaxis for pneumocystis pneumonia ( PCP ) in non-HIV immunocompromised patients (review). Cochrane Database Syst Rev. 2015:2014–6.

  64. Scherer K, Brockow K, Aberer W, Gooi JHC, Demoly P, Romano A, et al. Desensitization in delayed drug hypersensitivity reactions—an EAACI position paper of the drug allergy interest group. Allergy Eur. J Allergy Clin Immunol. 2013;68:844–52.

    Article  CAS  Google Scholar 

  65. Demoly P, Messaad D, Sahla H, Fabre J, Faucherre V, André P, et al. Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients. J Allergy Clin Immunol. 1998;102:1033–6.

  66. •• Lin D, Wk L, Mj R. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV / AIDS in patients with previous history of hypersensitivity to cotrimoxazole ( review ). Cochrane database Syst rev. 2007;CD005646 Systematic review of small trials in HIV patients showing desensitization of TMP-SMX resulted in fewer treatment discontinuations and reactions than did direct re-challenge.

  67. •• Pyle RC, Butterfield JH, Volcheck GW, Podjasek JC, Rank MA, Li JTC, et al. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction. J Allergy Clin Immunol Pract. 2014;2:52–8. Larger series showing high rates of successful desenzitiation to TMP-SMX in those with previously reported sulfonamide adverse drug reactions.

    Article  PubMed  Google Scholar 

  68. Hughes T, Almgren J, McGuffin R, Omoto R. Co-trimoxazole desensitization in bone marrow transplantation. Ann Intern Med. 1986;Jul:148.

  69. Soffritti S, Ricci G, Prete A, Rondelli R, Menna G, Pession A. Successful desensitization to trimethoprim-sulfamethoxazole after allogeneic haematopoietic stem cell transplantation: preliminary observations. Med Pediatr Oncol. 2003;Apr:271–2.

    Article  Google Scholar 

  70. Mann R, Badesch D, Zamora M, Dreskin S. Desensitization to trimethoprim-sulfamethoxazole following lung transplantation. Chest. 1997;111:1147.

    Article  PubMed  CAS  Google Scholar 

  71. Neuman MG, Shear NH, Malkiewicz IM, Kessas M, Lee AW, Cohen L. Predicting possible zonisamide hypersensitivity syndrome. Exp Dermatol. 2008;17:1045–51.

    Article  PubMed  Google Scholar 

  72. Alim N, Patel JY. Rapid oral desensitization to furosemide. Ann Allergy Asthma Immunol. 2009;103:538.

    Article  PubMed  Google Scholar 

  73. Wall GC, Bigner D, Craig S. Ethacrynic Acid and the sulfa-sensitive patient. Arch Intern Med. 2003;163:116–7.

    Article  PubMed  Google Scholar 

  74. Phipatanakul W, Adkinson NF Jr. Cross-reactivity between sulfonamides and loop or thiazide diuretics: is it a theoretical or actual risk? Allergy Clin Immunol Int [Internet]. 2000;12:26–8.

    Article  Google Scholar 

  75. Lee AG, Anderson R, Kardon RH, Wall M. Presumed sulfa allergy in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality? Am J Ophthalmol. 2004;138:114–8.

    Article  PubMed  CAS  Google Scholar 

  76. Mineo MC, Cheng EY. Severe allergic reaction to hydrochlorothiazide mimicking septic shock. Pharmacotherapy. 2009;29:357–61.

    Article  PubMed  Google Scholar 

  77. Mark Ruscin J, Page RL, Scott J. Hydrochlorothiazide-induced angioedema in a patient allergic to sulfonamide antibiotics: evidence from a case report and a review of the literature. Am J Geriatr Pharmacother. 2006;4:325–9.

    Article  PubMed  Google Scholar 

  78. De Barrio M, Tornero P, Zubeldia J, Sierra Z, Matheu V, Herrero T. Fixed drug eruption induced by indapamide. Cross-reactivity with sulfonamides. J Investig Allergol Clin Immunol. 1998;8:253–5.

    PubMed  Google Scholar 

  79. Gales BJ, Gales MA. Erythema multiforme and angioedema with indapamide and sertraline. Am J Hosp Pharm. 1994;51:118–9.

    PubMed  CAS  Google Scholar 

  80. Partanen J, Pohjola-Sintonen S, Makijarvi M. Toxic Epidermal Necrolysis due to Indapamide. Arch Dermatol. 1993;129:793.

  81. Stricker BH, Biriell C. Skin reactions and fever with indapamide. Br Med J (Clin Res Ed). 1987;295:1313–4.

    Article  CAS  Google Scholar 

  82. Zawodniak A, Lochmatter P, Beeler A, Pichler WJ. Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole. Int Arch Allergy Immunol. 2010;153:152–6.

    Article  PubMed  CAS  Google Scholar 

  83. Buijs BS, Van Den Berk GE, Boateng CP, Hoepelman AI, Van Maarseveen EM, Arends JE. Cross-reactivity between darunavir and trimethoprim- sulfamethoxazole in HIV-infected patients. AIDS. 2015;29:785–91.

    Article  PubMed  CAS  Google Scholar 

  84. Tibotec Therapeutics. PREZISTA darunavir ethanolate tablet. DAILYMED.National Libr. Med. (US). 2010. p. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm.

  85. Peralta J. Anaphylactic shock and death after oral intake of acetazolamide. Am J Ophthalmol. 1992;114:367–7.

  86. Tzanakis N, Metzidaki G, Thermos K, Spyraki CH, Bouros D. Anaphylactic shock after a single oral intake of acetazolamide. Br J Ophthalmol [Internet]. 1998;82:588.

    CAS  Google Scholar 

  87. Gharib A, Khokhar A, Caperton C V., Hamadani ST. Desensitization to acetazolamide in a patient with previous antimicrobial sulfonamide allergy. Ann Allergy, Asthma Immunol [Internet]. American College of Allergy, Asthma & Immunology; 2017;118:369–70. Available from: https://doi.org/10.1016/j.anai.2016.11.029

  88. Platt D, Griggs RC. Use of acetazolamide in sulfonamide-allergic patients with neurologic channelopathies. Arch Neurol 212AD. 69:527–9.

  89. Guedes GB, Karan A, Mayer HR, Shields MB. Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors. J Ocul Pharmacol Ther. 2013;29:456–61.

    Article  PubMed  CAS  Google Scholar 

  90. Holtzer CD, Flaherty JFJ, Coleman RL. Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone. Pharmacotherapy. 1998;18:831–5.

    PubMed  CAS  Google Scholar 

  91. Beumont MG, Graziani A, Ubel PA, MacGregor RR. Safety of dapsone as pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole. Am J Med. 1996;100:611–6.

    Article  PubMed  CAS  Google Scholar 

  92. Jorde UP, Horowitz HW, Wormser GP. Utility of dapsone for prophylaxis of pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. AIDS. 1993;7:355–9.

    Article  PubMed  CAS  Google Scholar 

  93. • May SM, Motosue MS, Park MA. Dapsone is often tolerated in HIV-infected patients with history of sulfonamide antibiotic intolerance. J Allergy Clin Immunol Pract. 2017;5:831–3. There is unlikely to be cross-reactivity between TMP-SMX and Dapsone in the HIV population.

    Article  PubMed  Google Scholar 

  94. Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with pneumocystis carinii pneumonia and AIDS. J Infect Dis [Internet] 1993;167:180–185. Available from: http://www.jstor.org/stable/30112589

  95. Blum RN, Miller LA, Gaggini LC, Cohn DL. Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr. 1992;5:341–7.

    PubMed  CAS  Google Scholar 

  96. Glasser DL, Pharm D, Burroughs SH. Valdecoxib-induced toxic epidermal necrolysis in a patient allergic to sulfa drugs. Pharmcotherapy. 2003;23:551–3.

    Article  Google Scholar 

  97. Figueroa J, Ortega N, Almeida L, Blanco C, Castillo R. Sulfonamide allergy without cross-reactivity to celecoxib. Allergy Eur. J Allergy Clin Immunol. 2007;

  98. Shapiro LE, Knowles SR, Weber E, Neuman MG, Shear NH. Safety of celecoxib in individuals allergic to sulfonamide: a pilot study. Drug Saf. 2003;26:187–95.

    Article  PubMed  CAS  Google Scholar 

  99. Patterson R, Bello AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther. 1999;

  100. Newman LC, Lay CL, O’Connor KA, Russell M. Lack of cross-reactivity to sumatriptan in patients allergic to sulfonamides: a retrospective chart review (abstract). Headache. 1999;5:372.

    Google Scholar 

  101. Bellón T, Lerma V, González-Valle O, González Herrada C, De Abajo FJ. Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds. Br J Dermatol. 2016;174:621–4.

    Article  PubMed  CAS  Google Scholar 

  102. Sinha R, Larkin J, Gore M, Fearfield L. Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation-positive metastatic melanoma, including recognition and management of rare presentations. Br J Dermatol. 2015;173:1024–31.

    Article  PubMed  CAS  Google Scholar 

  103. Anforth R, Carlos G, Clements A, Kefford R, Fernandez-Peñas P. Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks. Br J Dermatol. 2015;172:239–43.

    Article  PubMed  CAS  Google Scholar 

  104. Fisher A. Systemic contact dermatitis from Orinase and Diabinese in diabetics with Para-amino hypersensitivity. Curr Contact News. 1982;29:551.

    CAS  Google Scholar 

  105. Bukhalo M, Zeitouni NC, Cheney RT. Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross-reaction of a sulfonamide and a sulfonylurea. Cutis. 2003;71:235–8.

    PubMed  Google Scholar 

  106. Shenfield GM. Adverse drug reactions. Lancet. 2001;357:561.

    Article  PubMed  CAS  Google Scholar 

  107. Ritter FJ, Gustafson MC, Karney V, Penovich PE, Moriarty GL, Frost MD, et al. Do allergic reactions to sulfonamide antibiotics predict allergy to zonisamide? Epilepsia. 2002;43:209.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic, Division of Allergic Diseases, 200 First Street SW, Rochester, MN, 55905, USA

    Joshua M. Dorn, Mollie Alpern, Caitlin McNulty & Gerald W. Volcheck

Authors
  1. Joshua M. Dorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mollie Alpern
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Caitlin McNulty
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gerald W. Volcheck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerald W. Volcheck.

Ethics declarations

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Anaphylaxis and Drug Allergy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dorn, J.M., Alpern, M., McNulty, C. et al. Sulfonamide Drug Allergy. Curr Allergy Asthma Rep 18, 38 (2018). https://doi.org/10.1007/s11882-018-0791-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-018-0791-9

Keywords

Search

Navigation